|
|
|
| Current situation and development of import and export of Chinese pharmaceutical products under the background of “The Belt and Road” |
| PAN Qi1,2 WANG Juan3 XU Xiaoyuan1 GUO Mengjia2 |
1.School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu Province, Nanjing 211198, China;
2.School of Business, Zhejiang Pharmaceutical College, Zhejiang Province, Ningbo 315100, China;
3.School of Pharmaceutical Engineering, Zhejiang Pharmaceutical College, Zhejiang Province, Ningbo 315100, China |
|
|
|
Abstract The implementation of “The Belt and Road” Initiative has given some opportunities and challenges for Chinese pharmaceutical import and export. This paper expounds the effects of “The Belt and Road” Initiative on Chinese pharmaceutical industry, analyzes the situations of import and export between China and the countries along “The Belt and Road” after the initiative was launched respectively from Northeast Asia, Southeast Asia, South Asia, West Asia and North Africa, Central and Eastern Europe, Central Asia and other six countries in the Commonwealth of the Independent States, and finds the existing shortages of Chinese pharmaceutical foreign trade such as the low degree of industry concentration, the little difference on products, the insufficient innovation ability, and proposes some suggestions, such as developing the large pharmaceutical market along “The Belt and Road”, exploring the pharmaceutical market demand along “The Belt and Road”, improving the level of independent innovation technology, and studying the market access policy of the main countries along “The Belt and Road”, which will play a positive role in the further deepening of “The Belt and Road” Initiative in pharmaceutical industry.
|
|
|
|
|
|
[1] 王皓然.“一带一路”为中医药国际合作创造了机遇[EB/OL].2017-03-17. https：//www.yidaiyilu.gov.cn/ghsl/gnzjgd/7785.htm.
[2] 林凡儒.浅谈”一带一路”战略与中医药走出去[EB/OL].2016-03-07. http：//health.people.com.cn/n1/2016/0307/c3 98004-28179259.html.
[3] 崔芳.“一带一路”引燃中国医药发展热情[EB/OL].2017-08-18. http：//www.zjwjw.gov.cn/art/2017/8/18/art_1202105_9672587.html.
[4] 夏怀明.我国医药行业现状及市场结构分析[J].现代商业，2015（23）：140-141.
[5] 潘琪，邢梦雪，王隽，等.新常态下浙江省医药工业发展现状分析[J].中国医药工业杂志，2016，47（11）：1483-1486.
[6] 马守玉.借风“一带一路”中国医药走向世界[J].中国卫生，2016（1）：111.
[7] 竺彩华，韩剑夫.“一带一路”沿线FTA现状与中国FTA战略[J].亚太经济，2015（4）：44-50.
[8] 申现杰，肖金成.国际区域经济合作新形势与我国”一带一路”合作战略[J].宏观经济研究，2014（11）：30-38.
[9] 李剑力.“一带一路”贸易畅通的机制与促进对策研究[J].黄河科技大学学报，2015，17（6）：20-25.
[10] 黄立群.“一带一路”贸易畅通策略研究[J].国际贸易，2016（8）：52-56.
[11] 邹嘉龄，刘春腊，尹国庆，等.中国与“一带一路”沿线国家贸易格局及其经济贡献[J].地理科学进展，2015，34（5）：598-605.
[12] 罗芳.“一带一路”背景下中国出口贸易新发展研究[J].齐齐哈尔大学学报：哲学社会科学版，2015（12）：56-58.
[13] 梁琦，吴新生.“一带一路”沿线国家双边贸易影响因素研究——基于拓展引力方程的实证检验[J].经济学家，2016（12）：69-77.
[14] 黄先海，陈航宇.“一带一路”的实施效应研究——基于GTAP的模拟分析[J].社会科学战线，2016（5）：39-49.
[15] 吴沁.中国与“一带一路”国家贸易潜力研究[D].南京：南京大学，2016.
[16] 朱瑞雪.丝绸之路经济带背景下中国与中亚国家区域经贸合作研究[D].大连：东北财经大学，2015.
[17] 张晓燕，邱勇，章涤凡，等.“一带一路”战略下云药国际化发展的政策法规壁垒及对策分析[J].中国医药导报，2017，14（6）：176-180.
[18] 徐晓兵.借“一带一路”春风助兰州陇药扬帆远航[N].兰州日报，2015-07-21（004）.
[19] 胡芳.借东风加快发展，十三五期间医药行业要这么做[J].中国食品药品监管，2017（10）：34-35.
[20] 柳树.“一带一路”背景下中印医药产业合作：机遇、挑战与路径[J].南亚研究，2018（1）：50-67. |
|
|
|
